B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CIB1

MOLECULAR TARGET

calcium and integrin binding 1

NCBI Gene: 105199 compounds

CIB1 (calcium and integrin binding 1) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CIB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1celastrol1.102
2Disulfiram1.102
3Methylergonovine1.102
4Methysergide1.102
5Topotecan1.102
6darapladib [Supplementary Concept]0.691
7Ethylestrenol0.691
8Lysergic Acid Diethylamide Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is0.691
9Metergoline0.691

About CIB1 as a Drug Target

CIB1 (calcium and integrin binding 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented CIB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CIB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.